Prevalence of Inhibitor Development in Hemophilia A Patients Receiving Coageight: A Multicenter Cross-sectional Observational Study
Prevalence of Inhibitor Development in Hemophilia A Patients Receiving Coageight: A Multicenter Cross-sectional Observational Study
Not yet recruiting · NCT07791836 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevalence of Inhibitor Development in Hemophilia A Patients Receiving Coageight: A Multicenter Cross-sectional Observational Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Not yet recruiting | Not stated | 2026-08-28 | NCT07791836 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AryoGen Pharmed Co. | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Imam Khomeini Hospital | Tehran | Iran | 1 |
| Mofid Children's Hospital | Tehran | Iran | 1 |
| Seyyed al-Shohada Hospital | Isfahan | Iran | 1 |
| Shahid Ayatollah Dastgheib Hospital | Shiraz | Iran | 1 |
| Shahid Baqaei 2 Hospital | Ahvāz | Iran | 1 |
| Soroor Clinic | Mashhad | Iran | 1 |